la/mUCEnfortumab vedotinpembrolizumabchemotherapyEV–PemEV–Pem
…a lifetime horizon as primary outcomes.Results In patients with la/mUC, EV–Pem increased health outcomes by 0.82 QALYs (95% uncertaint…
Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
This disease is selected. Its supporting articles are shown below.
…a lifetime horizon as primary outcomes.Results In patients with la/mUC, EV–Pem increased health outcomes by 0.82 QALYs (95% uncertaint…
…therapy-naïve.Conclusions In this study, Japanese patients with la/mUC were more concerned about reduced quality of life due to advers…